Valproic acid-induced hyperammonaemic coma and unrecognised portosystemic shunt

Epileptic Disord. 2013 Jun;15(2):207-10. doi: 10.1684/epd.2013.0575.

Abstract

Hyperammonaemic encephalopathy is a rare and potentially fatal complication of valproic acid treatment. The clinical presentation of hyperammonaemic encephalopathy is wide and includes seizures and coma. We present a case of hyperammonaemic coma precipitated by sodium valproate use for symptomatic epilepsy in a patient with unrecognised portosystemic shunt, secondary to earlier alcoholism. The absence of any stigmata of chronic liver disease and laboratory markers of liver dysfunction delayed the recognition of this alcohol-related complication. The portal vein bypass led to a refractory, valproic acid-induced hyperammonaemic coma. The patient fully recovered after dialysis treatment.

Keywords: coma; hyperammonemia; portosystemic shunt; valproic acid.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / adverse effects*
  • Coma / chemically induced*
  • Coma / etiology
  • Humans
  • Hyperammonemia / chemically induced*
  • Hyperammonemia / etiology
  • Hypertension, Portal / complications*
  • Liver Diseases, Alcoholic / complications*
  • Male
  • Middle Aged
  • Valproic Acid / adverse effects*

Substances

  • Anticonvulsants
  • Valproic Acid